Making the Case for Investment in Rural Cancer Control: An Analysis of Rural Cancer Incidence, Mortality, and Funding Trends
Estimates of those living in rural counties vary from 46.2 to 59 million, or 14% to 19% of the U.S. Rural communities face disadvantages compared with urban areas, including higher poverty, lower educational attainment, and lack of access to health services. We aimed to demonstrate rural-urban dispa...
Gespeichert in:
| Veröffentlicht in: | Cancer epidemiology, biomarkers & prevention Jg. 26; H. 7; S. 992 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
01.07.2017
|
| Schlagworte: | |
| ISSN: | 1538-7755, 1538-7755 |
| Online-Zugang: | Weitere Angaben |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Estimates of those living in rural counties vary from 46.2 to 59 million, or 14% to 19% of the U.S.
Rural communities face disadvantages compared with urban areas, including higher poverty, lower educational attainment, and lack of access to health services. We aimed to demonstrate rural-urban disparities in cancer and to examine NCI-funded cancer control grants focused on rural populations. Estimates of 5-year cancer incidence and mortality from 2009 to 2013 were generated for counties at each level of the rural-urban continuum and for metropolitan versus nonmetropolitan counties, for all cancers combined and several individual cancer types. We also examined the number and foci of rural cancer control grants funded by NCI from 2011 to 2016. Cancer incidence was 447 cases per 100,000 in metropolitan counties and 460 per 100,000 in nonmetropolitan counties (
< 0.001). Cancer mortality rates were 166 per 100,000 in metropolitan counties and 182 per 100,000 in nonmetropolitan counties (
< 0.001). Higher incidence and mortality in rural areas were observed for cervical, colorectal, kidney, lung, melanoma, and oropharyngeal cancers. There were 48 R- and 3 P-mechanism rural-focused grants funded from 2011 to 2016 (3% of 1,655). Further investment is needed to disentangle the effects of individual-level SES and area-level factors to understand observed effects of rurality on cancer.
. |
|---|---|
| AbstractList | Estimates of those living in rural counties vary from 46.2 to 59 million, or 14% to 19% of the U.S.Estimates of those living in rural counties vary from 46.2 to 59 million, or 14% to 19% of the U.S.Rural communities face disadvantages compared with urban areas, including higher poverty, lower educational attainment, and lack of access to health services. We aimed to demonstrate rural-urban disparities in cancer and to examine NCI-funded cancer control grants focused on rural populations. Estimates of 5-year cancer incidence and mortality from 2009 to 2013 were generated for counties at each level of the rural-urban continuum and for metropolitan versus nonmetropolitan counties, for all cancers combined and several individual cancer types. We also examined the number and foci of rural cancer control grants funded by NCI from 2011 to 2016. Cancer incidence was 447 cases per 100,000 in metropolitan counties and 460 per 100,000 in nonmetropolitan counties (P < 0.001). Cancer mortality rates were 166 per 100,000 in metropolitan counties and 182 per 100,000 in nonmetropolitan counties (P < 0.001). Higher incidence and mortality in rural areas were observed for cervical, colorectal, kidney, lung, melanoma, and oropharyngeal cancers. There were 48 R- and 3 P-mechanism rural-focused grants funded from 2011 to 2016 (3% of 1,655). Further investment is needed to disentangle the effects of individual-level SES and area-level factors to understand observed effects of rurality on cancer. Cancer Epidemiol Biomarkers Prev; 26(7); 992-7. ©2017 AACR.POPULATIONRural communities face disadvantages compared with urban areas, including higher poverty, lower educational attainment, and lack of access to health services. We aimed to demonstrate rural-urban disparities in cancer and to examine NCI-funded cancer control grants focused on rural populations. Estimates of 5-year cancer incidence and mortality from 2009 to 2013 were generated for counties at each level of the rural-urban continuum and for metropolitan versus nonmetropolitan counties, for all cancers combined and several individual cancer types. We also examined the number and foci of rural cancer control grants funded by NCI from 2011 to 2016. Cancer incidence was 447 cases per 100,000 in metropolitan counties and 460 per 100,000 in nonmetropolitan counties (P < 0.001). Cancer mortality rates were 166 per 100,000 in metropolitan counties and 182 per 100,000 in nonmetropolitan counties (P < 0.001). Higher incidence and mortality in rural areas were observed for cervical, colorectal, kidney, lung, melanoma, and oropharyngeal cancers. There were 48 R- and 3 P-mechanism rural-focused grants funded from 2011 to 2016 (3% of 1,655). Further investment is needed to disentangle the effects of individual-level SES and area-level factors to understand observed effects of rurality on cancer. Cancer Epidemiol Biomarkers Prev; 26(7); 992-7. ©2017 AACR. Estimates of those living in rural counties vary from 46.2 to 59 million, or 14% to 19% of the U.S. Rural communities face disadvantages compared with urban areas, including higher poverty, lower educational attainment, and lack of access to health services. We aimed to demonstrate rural-urban disparities in cancer and to examine NCI-funded cancer control grants focused on rural populations. Estimates of 5-year cancer incidence and mortality from 2009 to 2013 were generated for counties at each level of the rural-urban continuum and for metropolitan versus nonmetropolitan counties, for all cancers combined and several individual cancer types. We also examined the number and foci of rural cancer control grants funded by NCI from 2011 to 2016. Cancer incidence was 447 cases per 100,000 in metropolitan counties and 460 per 100,000 in nonmetropolitan counties ( < 0.001). Cancer mortality rates were 166 per 100,000 in metropolitan counties and 182 per 100,000 in nonmetropolitan counties ( < 0.001). Higher incidence and mortality in rural areas were observed for cervical, colorectal, kidney, lung, melanoma, and oropharyngeal cancers. There were 48 R- and 3 P-mechanism rural-focused grants funded from 2011 to 2016 (3% of 1,655). Further investment is needed to disentangle the effects of individual-level SES and area-level factors to understand observed effects of rurality on cancer. . |
| Author | Blake, Kelly D Croyle, Robert T Moss, Jennifer L Srinivasan, Shobha Gaysynsky, Anna |
| Author_xml | – sequence: 1 givenname: Kelly D surname: Blake fullname: Blake, Kelly D email: kelly.blake@nih.gov organization: Division of Cancer Control and Population Sciences, NCI, NIH, Bethesda, Maryland. kelly.blake@nih.gov – sequence: 2 givenname: Jennifer L surname: Moss fullname: Moss, Jennifer L organization: Division of Cancer Control and Population Sciences, NCI, NIH, Bethesda, Maryland – sequence: 3 givenname: Anna surname: Gaysynsky fullname: Gaysynsky, Anna organization: Division of Cancer Control and Population Sciences, NCI, NIH, Bethesda, Maryland – sequence: 4 givenname: Shobha surname: Srinivasan fullname: Srinivasan, Shobha organization: Division of Cancer Control and Population Sciences, NCI, NIH, Bethesda, Maryland – sequence: 5 givenname: Robert T surname: Croyle fullname: Croyle, Robert T organization: Division of Cancer Control and Population Sciences, NCI, NIH, Bethesda, Maryland |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28600296$$D View this record in MEDLINE/PubMed |
| BookMark | eNpVkF9LwzAUxYNMnJt-BCWPPqwzSZs08W2UTQsbisznkuWPVrtkJq0w8MNbcYLChXvg_jj3njsCA-edAeACoynGlF9jRGkiBKPT-UOZ4DxBSJAjcIppypM8p3TwRw_BKMZXhFAuKD0BQ8IZQkSwU_C5km-1e4bti4GFjAZaH2DpPkxst8a1sHbwsQuy6YdOmQAL79rgmxs4c33JZh_rCL39D5VO1dr0cgJXPrSyqdv9BEqn4aJz-nvdOhin4xk4trKJ5vzQx-BpMV8Xd8ny_rYsZstEZaloE221YplA3OSYsP5uxZmhVjElxGZDZcqwTAmlmeGC2T4b1SyV1hLCcCqwIGNw9eO7C_6966NV2zoq0zTSGd_FCvfeGeFU8B69PKDdZmt0tQv1VoZ99fsx8gXGBm97 |
| CitedBy_id | crossref_primary_10_3389_fcvm_2022_927769 crossref_primary_10_1089_thy_2023_0357 crossref_primary_10_1002_hed_26783 crossref_primary_10_1093_jnci_djab096 crossref_primary_10_1007_s00520_022_07544_y crossref_primary_10_1016_j_whi_2017_09_008 crossref_primary_10_1111_jrh_12606 crossref_primary_10_3389_fonc_2023_1204821 crossref_primary_10_1097_NCC_0000000000000802 crossref_primary_10_1016_j_currproblcancer_2022_100893 crossref_primary_10_2217_mmt_2020_0023 crossref_primary_10_1111_jrh_12721 crossref_primary_10_1016_j_jaad_2021_03_086 crossref_primary_10_1053_j_gastro_2020_11_016 crossref_primary_10_1186_s12885_024_13040_9 crossref_primary_10_1016_j_ijrobp_2019_05_025 crossref_primary_10_1016_j_chest_2020_04_042 crossref_primary_10_1002_jgc4_1262 crossref_primary_10_1177_0272684X211065318 crossref_primary_10_1111_jrh_12615 crossref_primary_10_1200_GO_25_00018 crossref_primary_10_1097_MLR_0000000000002014 crossref_primary_10_1016_j_ijrobp_2022_06_075 crossref_primary_10_1111_jrh_12619 crossref_primary_10_1016_j_pec_2020_02_034 crossref_primary_10_1038_s41698_024_00547_4 crossref_primary_10_1007_s10147_022_02206_9 crossref_primary_10_2196_50392 crossref_primary_10_1002_pon_5596 crossref_primary_10_1097_MD_0000000000034692 crossref_primary_10_1111_jrh_12295 crossref_primary_10_1017_cts_2023_16 crossref_primary_10_3390_cancers17122051 crossref_primary_10_1016_j_ypmed_2019_105812 crossref_primary_10_1186_s12913_024_10916_1 crossref_primary_10_1186_s43058_020_00064_y crossref_primary_10_1007_s00520_020_05342_y crossref_primary_10_1001_jamanetworkopen_2023_50504 crossref_primary_10_1016_j_ygyno_2024_01_008 crossref_primary_10_1093_jncics_pkac017 crossref_primary_10_1016_j_jacr_2021_12_003 crossref_primary_10_1186_s43058_022_00311_4 crossref_primary_10_3390_ijerph19041916 crossref_primary_10_1007_s10552_021_01546_7 crossref_primary_10_1007_s00520_020_05497_8 crossref_primary_10_1016_j_cct_2021_106654 crossref_primary_10_1200_EDBK_238965 crossref_primary_10_1245_s10434_022_11834_4 crossref_primary_10_1097_MLR_0000000000001028 crossref_primary_10_1016_j_ypmed_2019_105821 crossref_primary_10_5888_pcd18_210091 crossref_primary_10_1007_s10552_023_01673_3 crossref_primary_10_1007_s13187_021_02069_0 crossref_primary_10_1186_s43058_022_00285_3 crossref_primary_10_1177_21501319241288025 crossref_primary_10_3390_app14125332 crossref_primary_10_1177_08901171241257051 crossref_primary_10_1002_cam4_70187 crossref_primary_10_1007_s11606_022_07922_6 crossref_primary_10_1007_s13187_020_01908_w crossref_primary_10_1513_AnnalsATS_202103_333OC crossref_primary_10_1002_cncr_32607 crossref_primary_10_1002_lary_30809 crossref_primary_10_1111_jrh_12881 crossref_primary_10_1111_jrh_12520 crossref_primary_10_1093_jnci_djac030 crossref_primary_10_1111_ijd_16459 crossref_primary_10_1038_s41598_022_18374_7 crossref_primary_10_1111_hex_13840 crossref_primary_10_1007_s11912_023_01415_3 crossref_primary_10_1002_cncr_33810 crossref_primary_10_1016_j_cct_2025_108005 crossref_primary_10_1186_s12913_023_09994_4 crossref_primary_10_1111_jrh_12414 crossref_primary_10_1002_cncr_33256 crossref_primary_10_1016_j_ypmed_2020_106407 crossref_primary_10_1016_j_cct_2024_107539 crossref_primary_10_1097_MLR_0000000000001691 crossref_primary_10_1007_s00520_025_09208_z crossref_primary_10_1002_cam4_4944 crossref_primary_10_1007_s10552_023_01743_6 crossref_primary_10_3390_ijerph18041384 crossref_primary_10_1177_21501319241259915 crossref_primary_10_1186_s12885_021_08949_4 crossref_primary_10_15580_gjeph_2025_1_081125118 crossref_primary_10_1016_j_jaad_2020_08_092 crossref_primary_10_1016_j_conctc_2024_101399 crossref_primary_10_1111_jrh_12781 crossref_primary_10_1111_jrh_12420 crossref_primary_10_1111_jrh_12663 crossref_primary_10_1007_s13187_025_02708_w crossref_primary_10_1002_pon_5566 crossref_primary_10_1002_cncr_32398 crossref_primary_10_1200_GO_23_00238 crossref_primary_10_2196_66636 crossref_primary_10_1186_s12889_025_22134_3 crossref_primary_10_3390_ijerph19116874 crossref_primary_10_1093_jnci_djac038 crossref_primary_10_1111_jrh_12550 crossref_primary_10_1007_s10552_024_01851_x crossref_primary_10_1007_s10552_022_01599_2 crossref_primary_10_4251_wjgo_v16_i4_1374 crossref_primary_10_1093_jnci_djab139 crossref_primary_10_3389_fonc_2024_1373905 crossref_primary_10_1186_s40959_023_00167_0 crossref_primary_10_1097_JHQ_0000000000000354 crossref_primary_10_1002_cnr2_1354 crossref_primary_10_1007_s00520_020_05674_9 crossref_primary_10_1111_jpc_16469 crossref_primary_10_1016_j_canep_2023_102512 crossref_primary_10_1186_s12913_024_12014_8 crossref_primary_10_1002_cncr_32651 crossref_primary_10_1007_s11764_024_01546_x crossref_primary_10_1093_jnci_djab006 crossref_primary_10_5888_pcd19_210450 crossref_primary_10_1016_j_amepre_2021_05_021 crossref_primary_10_1016_j_jss_2022_10_097 crossref_primary_10_1016_j_jgo_2020_09_003 crossref_primary_10_1007_s10549_022_06830_x crossref_primary_10_1007_s10900_021_01035_7 crossref_primary_10_1177_1178223419876296 crossref_primary_10_1177_12034754241247521 crossref_primary_10_1002_cnr2_1221 crossref_primary_10_3390_ijerph16030436 crossref_primary_10_1089_jayao_2019_0102 crossref_primary_10_1177_12034754221149653 crossref_primary_10_1188_19_ONF_654_669 crossref_primary_10_3389_fmed_2025_1427136 crossref_primary_10_1111_jrh_12455 crossref_primary_10_1111_jrh_12335 crossref_primary_10_1016_j_puhe_2020_09_018 crossref_primary_10_1089_jwh_2021_0517 crossref_primary_10_1016_j_jcpo_2023_100465 crossref_primary_10_1177_10732748221102819 crossref_primary_10_1111_jrh_12571 crossref_primary_10_1016_j_urolonc_2019_03_004 crossref_primary_10_1016_j_ssmqr_2024_100519 crossref_primary_10_5888_pcd19_220104 crossref_primary_10_1089_heq_2021_0068 crossref_primary_10_1249_TJX_0000000000000288 crossref_primary_10_1177_23743735241239865 crossref_primary_10_1002_cam4_7058 crossref_primary_10_1188_21_CJON_S1_10_16 crossref_primary_10_1007_s10552_024_01867_3 crossref_primary_10_1016_j_jth_2019_100625 crossref_primary_10_1002_cncr_31541 crossref_primary_10_1017_cts_2025_10123 crossref_primary_10_1016_j_imr_2021_100755 crossref_primary_10_1371_journal_pone_0331685 crossref_primary_10_1016_j_ijrobp_2023_10_030 crossref_primary_10_1093_jnci_djac238 crossref_primary_10_1111_add_16355 crossref_primary_10_1007_s11136_020_02683_3 crossref_primary_10_1016_j_jss_2019_03_008 crossref_primary_10_1016_j_ypmed_2023_107588 crossref_primary_10_1002_ajim_23524 crossref_primary_10_3390_ijerph182412909 crossref_primary_10_1007_s10552_020_01375_0 crossref_primary_10_1016_j_jtho_2017_12_010 crossref_primary_10_1093_jncics_pkaa100 crossref_primary_10_1186_s12885_021_08985_0 crossref_primary_10_1111_jrh_12357 crossref_primary_10_1177_23333936221111802 crossref_primary_10_1016_j_jacr_2022_12_019 crossref_primary_10_1186_s12911_021_01549_z crossref_primary_10_1111_jrh_12359 crossref_primary_10_1007_s11912_024_01534_5 crossref_primary_10_1016_j_jss_2021_09_042 crossref_primary_10_1111_jrh_12590 crossref_primary_10_1111_jrh_12350 crossref_primary_10_1007_s00520_019_05005_7 crossref_primary_10_1007_s40615_025_02517_3 crossref_primary_10_1016_j_jaad_2024_01_042 crossref_primary_10_1016_j_ypmed_2019_105835 crossref_primary_10_1245_s10434_021_11304_3 crossref_primary_10_1016_j_cct_2023_107276 crossref_primary_10_1093_eurheartj_ehae047 crossref_primary_10_1186_s12913_021_06489_y crossref_primary_10_1016_j_canep_2021_102033 crossref_primary_10_1111_jrh_12364 crossref_primary_10_1016_j_suronc_2024_102034 crossref_primary_10_1016_j_suc_2024_11_008 crossref_primary_10_1186_s12913_022_08976_2 crossref_primary_10_1016_j_worlddev_2022_105941 crossref_primary_10_1016_j_ypmed_2019_105849 crossref_primary_10_1093_jncimonographs_lgae003 crossref_primary_10_1016_j_jgo_2021_04_002 crossref_primary_10_1002_cam4_6830 crossref_primary_10_1007_s00520_019_05134_z crossref_primary_10_1111_jrh_12498 crossref_primary_10_1016_j_jacr_2023_01_003 crossref_primary_10_1080_13557858_2022_2056145 crossref_primary_10_1093_tbm_ibz035 crossref_primary_10_1016_j_amjsurg_2023_09_029 crossref_primary_10_1016_j_jth_2024_101819 crossref_primary_10_1016_j_jaad_2020_07_125 crossref_primary_10_3390_ijerph192315887 crossref_primary_10_1007_s13187_020_01696_3 crossref_primary_10_1007_s13187_020_01819_w crossref_primary_10_1016_j_canep_2020_101681 crossref_primary_10_1111_jrh_12821 crossref_primary_10_1007_s00520_024_08457_8 crossref_primary_10_1016_j_ypmed_2021_106759 crossref_primary_10_1245_s10434_025_17291_z crossref_primary_10_1007_s10865_023_00400_2 crossref_primary_10_1016_j_ygyno_2021_07_035 crossref_primary_10_1111_jrh_12263 crossref_primary_10_1016_j_urolonc_2023_12_011 crossref_primary_10_1016_j_amepre_2020_03_019 crossref_primary_10_1200_EDBK_390678 crossref_primary_10_1007_s13187_024_02550_6 crossref_primary_10_3390_nu15183998 crossref_primary_10_1016_j_japh_2023_09_004 crossref_primary_10_1001_jamanetworkopen_2022_12246 crossref_primary_10_1016_j_amepre_2021_09_021 crossref_primary_10_3389_fonc_2024_1374403 crossref_primary_10_1007_s10552_022_01621_7 crossref_primary_10_1002_pon_5616 crossref_primary_10_1089_whr_2021_0082 crossref_primary_10_1097_PPO_0000000000000686 crossref_primary_10_1111_jrh_12399 crossref_primary_10_1136_jech_2019_212425 crossref_primary_10_14423_SMJ_0000000000001171 crossref_primary_10_1186_s12913_025_12988_z crossref_primary_10_1016_j_jcpo_2020_100262 crossref_primary_10_1007_s10552_023_01819_3 crossref_primary_10_1186_s12875_022_01845_1 crossref_primary_10_11124_JBIES_21_00256 crossref_primary_10_1016_j_canep_2024_102705 |
| ContentType | Journal Article |
| Copyright | 2017 American Association for Cancer Research. |
| Copyright_xml | – notice: 2017 American Association for Cancer Research. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1158/1055-9965.EPI-17-0092 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1538-7755 |
| ExternalDocumentID | 28600296 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Intramural NIH HHS grantid: Z99 CA999999 |
| GroupedDBID | --- .55 18M 29B 2FS 2WC 34G 39C 3O- 53G 5GY 5VS 6J9 AAFWJ ABOCM ACPRK ADBBV ADCOW AENEX AFHIN AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BR6 BTFSW C1A CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD F5P FRP H13 H~9 IH2 KQ8 L7B NPM OK1 P2P PQQKQ QTD RCR RHI SJN UDS VH1 W8F WHG WOQ X7M ZXP 7X8 |
| ID | FETCH-LOGICAL-c439t-dfdc64908e7126029c86e5fc6c99bb5a361a32554e896f2865d63aff226139192 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 303 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000415229200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1538-7755 |
| IngestDate | Fri Jul 11 12:18:29 EDT 2025 Mon Jul 21 05:50:34 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | 2017 American Association for Cancer Research. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c439t-dfdc64908e7126029c86e5fc6c99bb5a361a32554e896f2865d63aff226139192 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/5500425 |
| PMID | 28600296 |
| PQID | 1908428598 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_1908428598 pubmed_primary_28600296 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-07-01 |
| PublicationDateYYYYMMDD | 2017-07-01 |
| PublicationDate_xml | – month: 07 year: 2017 text: 2017-07-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Cancer epidemiology, biomarkers & prevention |
| PublicationTitleAlternate | Cancer Epidemiol Biomarkers Prev |
| PublicationYear | 2017 |
| SSID | ssj0007955 |
| Score | 2.640113 |
| SecondaryResourceType | review_article |
| Snippet | Estimates of those living in rural counties vary from 46.2 to 59 million, or 14% to 19% of the U.S.
Rural communities face disadvantages compared with urban... Estimates of those living in rural counties vary from 46.2 to 59 million, or 14% to 19% of the U.S.Estimates of those living in rural counties vary from 46.2... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 992 |
| SubjectTerms | Financing, Government - standards Financing, Government - trends Healthcare Disparities - statistics & numerical data Healthcare Disparities - trends Humans Incidence National Cancer Institute (U.S.) - economics National Cancer Institute (U.S.) - statistics & numerical data National Cancer Institute (U.S.) - trends Neoplasms - epidemiology Neoplasms - therapy Rural Health - standards Rural Health - trends Rural Health Services - economics Rural Health Services - organization & administration Rural Health Services - statistics & numerical data Rural Health Services - trends Rural Population - statistics & numerical data SEER Program - statistics & numerical data United States Urban Health Urban Health Services - economics Urban Health Services - organization & administration Urban Health Services - statistics & numerical data Urban Health Services - trends Urban Population - statistics & numerical data |
| Title | Making the Case for Investment in Rural Cancer Control: An Analysis of Rural Cancer Incidence, Mortality, and Funding Trends |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28600296 https://www.proquest.com/docview/1908428598 |
| Volume | 26 |
| WOSCitedRecordID | wos000415229200002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA7qRHzxfpk3Ivi4OLq0ufgiMjYU7BiisreS5gJ7aecuPvnjPUk7hg-C4Ev60JaW5OScLzkn34fQDXeRYC4XJOfakjhyCuaciIhRDOyHMsoDA9_7Mx8MxGgkh_WG26wuq1z6xOCoTan9HnkbApeIPduauJ98EK8a5bOrtYTGOmpQgDLeqvloxRbOZVA9DZOa8ySpT_BEiWh7XUgCWD-57Q2fCHhqTz70O8oM0aa_-9__3EM7Nc7ED5Vh7KM1WxygrbTOpB-irzTIUGHAf7gLkQwDeMUV6YbfL8TjAr94Rg64CWYxxd2qpP0OPxR4SWSCS_fzIXA2lUZpC6cB1gPEb2FVGNxfhNMzuCrBPUJv_d5r95HUSgxEA2CZE-OMZj5FaHkEC6CO1ILZxGmmpczzRFEWKQqLk9gKyZw_7GoYVc4BtoNhARB5jDaKsrCnCFNupI21gVbEcFU8YdZy5qiEeGpFE10v-zUDS_fpC1XYcjHLVj3bRCfV4GSTipIjg0_6_CI7-8Pb52i742NzqLm9QA0H89xeok39OR_PplfBhKAdDNNvGDTOuA |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Making+the+Case+for+Investment+in+Rural+Cancer+Control%3A+An+Analysis+of+Rural+Cancer+Incidence%2C+Mortality%2C+and+Funding+Trends&rft.jtitle=Cancer+epidemiology%2C+biomarkers+%26+prevention&rft.au=Blake%2C+Kelly+D&rft.au=Moss%2C+Jennifer+L&rft.au=Gaysynsky%2C+Anna&rft.au=Srinivasan%2C+Shobha&rft.date=2017-07-01&rft.eissn=1538-7755&rft.volume=26&rft.issue=7&rft.spage=992&rft_id=info:doi/10.1158%2F1055-9965.EPI-17-0092&rft_id=info%3Apmid%2F28600296&rft_id=info%3Apmid%2F28600296&rft.externalDocID=28600296 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7755&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7755&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7755&client=summon |